LBA44 - Pembrolizumab with or without chemotherapy vs chemotherapy in patients with advanced G/GEJ cancer (GC) including outcomes according to Microsatellite Instability-High (MSI-H) status in KEYNOTE-062

Autor:	Shitara, K. 1, Van Cutsem, E. 2, Bang, Y.-J. 3, Fuchs, C.S. 4, Wyrwicz, L. 5, Lee, K.W. 6, Kudaba, I. 7, Garrido, M. 8, Cheol Chung, H. 9, Castro, H.R. 10, Mansoor, W. 11, Braghiroli, M I F M 12, Goekkurt, E. 13, Chao, J. 14, Wainberg, Z.A. 15, Kher, U. 16, Shah, S. 16, Kang, S.P. 16, Tabernero, J. 17
Zdroj:	In Annals of Oncology October 2019 30 Supplement 5:v878-v879
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu